FDA Import Refusal 112-6095832-2/2/1 — Glaxo Smith Kline

Glaxo Smith Kline — FEI 3004006471

The FDA refused shipment 112-6095832-2/2/1 from Glaxo Smith Kline (United States) on Mar 6, 2012. The refused product falls under Drugs and Biologics — CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Mar 6, 2012
Country
United States
Product Category
Drugs and Biologics
Product Code
61XBA45 CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.